aminophylline has been researched along with Chronic Lung Injury in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berthiaume, Y; Ferraro, P; Massé, C; Richard, C; Shabbir, W | 1 |
| Chang, ML; Chen, HI; Hsu, K; Wang, D; Wu, CP | 1 |
| Bysani, GK; Gurtner, GH; Hasty, D; Hoidal, JR; Hopkins, C; Kennedy, TP; Lazar, R; Michael, JR; Sciuto, AM; Tolley, E | 1 |
3 other study(ies) available for aminophylline and Chronic Lung Injury
| Article | Year |
|---|---|
Alveolar liquid clearance in lung injury: Evaluation of the impairment of the β
Topics: Aminophylline; Animals; Blood Pressure; Bronchodilator Agents; Cyclic AMP; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Epithelial Sodium Channels; Female; Heart Rate; Imidazoles; Iodine Radioisotopes; Iodocyanopindolol; Lung Injury; Male; Propanolamines; Protein Binding; Pulmonary Alveoli; Pulmonary Edema; Receptors, Adrenergic, beta-2; Reperfusion Injury; RNA, Messenger | 2019 |
Pulmonary edema induced by phorbol myristate acetate is attenuated by compounds that increase intracellular cAMP.
Topics: Adrenergic beta-Agonists; Aminophylline; Animals; Blood Pressure; Bucladesine; Capillary Permeability; Cyclic AMP; Disease Models, Animal; Humans; Lung; Lung Injury; Male; Neutrophils; Phosphodiesterase Inhibitors; Pulmonary Artery; Pulmonary Edema; Rabbits; Respiratory Distress Syndrome; Terbutaline; Tetradecanoylphorbol Acetate; Tumor Necrosis Factor-alpha | 1996 |
Dibutyryl cAMP, aminophylline, and beta-adrenergic agonists protect against pulmonary edema caused by phosgene.
Topics: Aminophylline; Animals; Bucladesine; Isoproterenol; Lung; Lung Injury; Malondialdehyde; Phosgene; Pulmonary Edema; Rabbits; Terbutaline | 1989 |